Napp Pharmaceuticals is rapidly responding to the evolving coronavirus (COVID-19) pandemic to ensure the reliable supply and distribution of all our medicines to patients that depend on them remains uninterrupted.
Our commitment to protecting the health of all our employees, partners, suppliers and contractors, also continues to be a priority during this difficult time.
Napp Pharmaceuticals has always embraced flexible working and all our employees and contractors that are able to do so, are equipped to work effectively from home. For our people with roles that require them to be on-site, such as supply and manufacturing, our site health and safety teams are actively following and acting upon all relevant WHO and national health authority recommendations.
As the global situation develops, we will continue to assess what actions are required and take the necessary steps to safeguard the supply of our medicines and our workforce and will communicate any significant changes that may arise during this critical time.